84. Sarcoidosis
143 clinical trials,   221 drugs   (DrugBank: 79 drugs),   82 drug target genes,   165 drug target pathways
Searched query = "Sarcoidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02643732 (ClinicalTrials.gov) | November 2016 | 23/12/2015 | Fatigue in Sarcoidosis - Treatment With Methylphenidate | Fatigue in Sarcoidosis - A Feasibility Study Investigating the Treatment of Fatigue in Stable Sarcoidosis Patients Using Methylphenidate | Sarcoidosis;Fatigue | Drug: Methylphenidate (overencapsulated);Drug: Placebo (Over-encapsulated tablet) | University of East Anglia | Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK) | Recruiting | 18 Years | N/A | All | 30 | N/A | United Kingdom |
2 | EUCTR2016-000342-60-GB (EUCTR) | 21/06/2016 | 06/02/2019 | Fatigue and Sarcoidosis: Treatment with Methylphenidate | Fatigue in Sarcoidosis - A feasibility study investigating the treatment of fatigue in stable sarcoidosis patients using methylphenidate - Fatigue in Sarcoidosis: Treatment with Methylphenidate | Sarcoidosis-associated fatigue (Patients with stable sarcoidosis and chronic fatigue) MedDRA version: 20.1;Level: PT;Classification code 10039486;Term: Sarcoidosis;System Organ Class: 10021428 - Immune system disorders ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] | Norfolk and Norwich University Hospital | NULL | Not Recruiting | Female: yes Male: yes | 30 | Phase 2 | United Kingdom | |||
3 | NCT00361387 (ClinicalTrials.gov) | June 2006 | 7/8/2006 | Use of Focalin for Fatigue in Sarcoidosis | Randomized, Double-Blind, Placebo-Controlled Study of Dexmethylphenidate Hydrochloride, (d-MPH) in the Treatment of Fatigue in Sarcoidosis Subjects. | Sarcoidosis | Drug: d-methylphenidate | University of Cincinnati | NULL | Completed | 18 Years | N/A | Both | 12 | Phase 4 | United States |